Literature DB >> 17293450

The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone.

Andrea Romano1, Bert Delvoux, Dagmar-Christiane Fischer, Patrick Groothuis.   

Abstract

The human progesterone receptor (PR) is a ligand-dependent transcription factor and two isoforms, (PRA and PRB), can be distinguished. PROGINS, a PR polymorphic variant, affects PRA and PRB and acts as a risk-modulating factor in several gynaecological disorders. Little is known about the functional consequences of this variant. Here, we characterise the properties of PROGINS with respect to transcription, mRNA maturation, protein activity and proliferation. PROGINS is characterised by a 320 bp PV/HS-1 Alu insertion in intron G and two point mutations, V660L in exon 4 and H770H (silent substitution) in exon 5. The Alu element contains a half oestrogen-response element/Sp1-binding site (Alu-ERE/Sp1), which acts as an in-cis intronic enhancer leading to increased transcription of the PROGINS allele in response to 17beta-oestradiol. Moreover, Alu insertions in the human genome are frequently methylated. Our data indicate that the PROGINS-Alu does not affect gene transcription due to DNA methylation. However, the Alu element reduced the stability of the PROGINS transcript compared with the CP allele and does not generate splice variants. The amino acid substitution (V600L) in exon 4 leads to differences in PR phosphorylation and degradation in the two PR variants upon ligand binding, most likely as a result of differences in the three-dimensional structures of the two PR variants. As a consequence, the PR-L660 (PROGINS) variant (1) displays decreased transactivation activity in a luciferase reporter system and (2) is less efficient in opposing cell proliferation in hamster ovarian cells expressing human PRA, when compared with the PR-V660 (most common variant). Taken together, our results indicate that the PROGINS variant of PR is less responsive to progestin compared with the most common PR because of (i) reduced amounts of gene transcript and (ii) decreased protein activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293450     DOI: 10.1677/jme.1.02170

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  32 in total

1.  Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.

Authors:  Hellen Dassen; Chamindie Punyadeera; Bert Delvoux; Iris Schulkens; Claudia Marchetti; Rick Kamps; Jan Klomp; Fred Dijcks; Anton de Goeij; Thomas D'Hooghe; Cleophas Kyama; Antwan Ederveen; Gerard Dunselman; Patrick Groothuis; Andrea Romano
Journal:  Am J Pathol       Date:  2010-11       Impact factor: 4.307

Review 2.  Genomics of preterm birth.

Authors:  Kayleigh A Swaggart; Mihaela Pavlicev; Louis J Muglia
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

3.  Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.

Authors:  Rabeb M Ghali; Maryam A Al-Mutawa; Bashayer H Ebrahim; Hanen H Jrah; Sonia Zaied; Hanen Bhiri; Fahmi Hmila; Touhami Mahjoub; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2018-01-04       Impact factor: 3.201

4.  Associations of progesterone receptor polymorphisms with age at menarche and menstrual cycle length.

Authors:  K C Taylor; C M Small; M P Epstein; S L Sherman; W Tang; M M Wilson; M Bouzyk; M Marcus
Journal:  Horm Res Paediatr       Date:  2010-09-02       Impact factor: 2.852

5.  Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.

Authors:  Eunjung Lee; Sue A Ingles; David Van Den Berg; Wei Wang; Chris Lavallee; Mei-Hua Huang; Carolyn J Crandall; Frank Z Stanczyk; Gail A Greendale; Giske Ursin
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

6.  Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.

Authors:  Eunjung Lee; Chris Hsu; Christopher A Haiman; Pedram Razavi; Pamela L Horn-Ross; David Van Den Berg; Leslie Bernstein; Loic Le Marchand; Brian E Henderson; V Wendy Setiawan; Giske Ursin
Journal:  Carcinogenesis       Date:  2010-06-13       Impact factor: 4.944

7.  Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine.

Authors:  Raffaele Palmirotta; Piero Barbanti; Cristiano Ialongo; Maria Laura De Marchis; Jhessica Alessandroni; Gabriella Egeo; Cinzia Aurilia; Luisa Fofi; Maria Giovanna Valente; Patrizia Ferroni; David Della-Morte; Fiorella Guadagni
Journal:  DNA Cell Biol       Date:  2014-12-10       Impact factor: 3.311

8.  Disrupted cell cycle control in cultured endometrial cells from patients with endometriosis harboring the progesterone receptor polymorphism PROGINS.

Authors:  Paulo D'Amora; Thiago Trovati Maciel; Rodrigo Tambellini; Marcelo A Mori; João Bosco Pesquero; Helio Sato; Manoel João Batista Castello Girão; Ismael Dale Cotrim Guerreiro da Silva; Eduardo Schor
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

9.  Evaluation of fetal and maternal genetic variation in the progesterone receptor gene for contributions to preterm birth.

Authors:  Nicole L Ehn; Margaret E Cooper; Kristin Orr; Min Shi; Marla K Johnson; Diana Caprau; John Dagle; Katherine Steffen; Karen Johnson; Mary L Marazita; David Merrill; Jeffrey C Murray
Journal:  Pediatr Res       Date:  2007-11       Impact factor: 3.756

Review 10.  Sex steroid-related candidate genes in psychiatric disorders.

Authors:  Lars Westberg; Elias Eriksson
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.